JF
ALDX icon

Jump Financial’s Aldeyra Therapeutics ALDX Stock Holding History

Jump Financial’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,480
Closed -$127K – 1843
2025
Q4 		$127K Buy
+24,480
New +$126K ﹤0.01% 1810
2023
Q2 		– Sell
-24,903
Closed -$247K – 1762
2023
Q1 		$247K Buy
24,903
+9,397
+61% +$66.4K 0.01% 1213
2022
Q4 		$108K Sell
15,506
-34,494
-69% -$197K 0.01% 1414
2022
Q3 		$267K Buy
+50,000
New +$300K 0.01% 1202
2021
Q3 		– Sell
-69,215
Closed -$784K – 1071
2021
Q2 		$784K Buy
+69,215
New +$832K 0.08% 328
2021
Q1 		– Sell
-19,900
Closed -$137K – 907
2020
Q4 		$137K Buy
+19,900
New +$140K 0.02% 834

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jump Financial's ALDX Position: Q1 2026 in Review

Jump Financial sold out of Aldeyra Therapeutics (ALDX) in Q1 2026, closing a stake of 24,480 shares — an estimated $127K sold.

Jump Financial first reported a position in ALDX in Q4 2020 and held it in 6 quarters. The position peaked at $784K in Q2 2021. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • Jump Financial reported no remaining Aldeyra Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 24,480 Aldeyra Therapeutics shares in Q1 2026, an estimated $127K.
  • Jump Financial first reported a position in Aldeyra Therapeutics in Q4 2020 and held it in 6 quarters.
  • Jump Financial's Aldeyra Therapeutics position peaked at $784K in Q2 2021.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.